Pathophysiology of Preeclampsia-Induced Vascular Dysfunction and Implications for Subclinical Myocardial Damage and

Leslee J Shaw1,2,3,4,5, Krishna Patel1,2,3,4, Anuradha Lala-Trindade3

  • 1Blavatnik Family Women's Health Research Institute, New York, New York, USA.

JACC. Advances
|June 28, 2024
PubMed

Insights

Preeclampsia, especially early onset, significantly elevates cardiovascular disease and heart failure risk, particularly in Black women. Closer postpartum monitoring is crucial to manage hypertension and prevent long-term cardiac complications.

Area of Science:

  • Obstetrics and Gynecology
  • Cardiology
  • Maternal-Fetal Medicine

Background:

  • Preeclampsia is a major cause of pregnancy complications and increases long-term cardiovascular disease (CVD) risk.
  • Distinct early (<34 weeks) and late preeclampsia pathways exist, differing in maternal and infant risks.
  • Black women face the highest risk for preeclampsia and subsequent heart failure (HF).

Purpose of the Study:

  • To elucidate the mechanisms linking preeclampsia to heightened cardiovascular disease risk.
  • To differentiate the perinatal and postpartum risks associated with early versus late preeclampsia.
  • To highlight the long-term cardiac sequelae and identify high-risk populations.

Main Methods:

  • The study reviews evidence suggesting distinct pathophysiological pathways for early and late preeclampsia.
  • Analysis focuses on systemic vascular dysfunction, myocardial damage, and persistent postpartum cardiac abnormalities.
  • Epidemiological data on risk factors and long-term outcomes, particularly in Black women, are considered.

Main Results:

  • Early preeclampsia (<34 weeks) is associated with systemic vascular dysfunction and subclinical myocardial damage.
  • Postpartum, persistent hypertrophy and diastolic dysfunction contribute to early-onset heart failure (HF).
  • HF risk remains elevated for decades, increasing premature mortality, with Black women at highest risk.

Conclusions:

  • Early and severe preeclampsia necessitate closer postpartum surveillance for chronic hypertension management.
  • Interventions aimed at controlling hypertension can mitigate preventable CVD and HF sequelae.
  • Understanding distinct preeclampsia pathways is key to reducing long-term maternal cardiovascular morbidity and mortality.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.2K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
627
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
419
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K